Clinical care observation of PMT combined with low-dose alteplase CDT for acute deep vein thrombosis
PMT联合小剂量阿替普酶CDT治疗急性下肢深静脉血栓的临床护理观察

摘要

目的 探讨使用不同护理方法对急性下肢深静脉血栓患者的疗效和安全性。方法 将2020年8月至2023年6月在我院接受治疗的42例急性下肢深静脉血栓患者随机分为A组（PMT+CDT-尿激酶组）和B组（PMT+CDT-rTPA组），其中A组22例，B组20例，比较各组患者的平均血栓清除率和6月后的PTS发生率。结果 B组患者的平均血栓清除率为（90.12±2.34）%高于A组（85.32±2.14）%（P<0.05），且B组患者的6月后PTS发生率为10%低于A组（9%）（P>0.05）。结论 PMT+CDT结合使用rTPA治疗急性下肢深静脉血栓具有更好的临床护理治疗效果，值得在临床进行大量推广和应用。

Abstract

Objective To explore the efficacy and safety of different nursing methods in patients with acute deep vein thrombosis.
Methods The 42 patients with acute DVT treated in our hospital from August 2020 to June 20203 were randomly divided into group A (PMT + CDT-urokinase group) and group B (PMT + CDT-rTPA group), including 22 group A and 20 group B to compare the mean thrombus clearance of patients in each group and the incidence of PTS after 6 months.
Results The mean thrombus clearance in Group B was (90.12 ± 2.34)% higher than in Group A (85.32 ± 2.14)% (P <0.05), and the post-month PTS in Group B was 10% lower than in Group A (9%) (P> 0.05).
Conclusion   PMT + CMT CDT combined with rTPA for acute lower extremity DVT has better clinical nursing treatment effect, which is worth extensive promotion and application in clinical practice.